Considering the high prevalence of PTEN mutations in prostate cancer cases in Jordan and the scarcity of data on the independent correlation between PTEN expression status and ADT response, this follow-up study aimed to determine the relationship between PTEN loss and time to castration-resistance following ADT in a prostate cancer cohort from Jordan. This evidence concerns the gene PTEN and prostate carcinoma.